Skip to main content

Table 2 Treatment

From: Paediatric non-infectious uveitis in Cape Town, South Africa: a retrospective review of disease characteristics and outcomes on immunomodulating treatment

Treatment

Total treated

N

Response

(R) / No

Response (NR)

JIAU N = 14

Idiopathic N = 12

Sarcoidosis

N = 2

Behcet’s Disease

N = 1

Total N (%)

Screening

N = 11

Pre-JIA diagnosis N = 3

Standard Initial Rx

29

R

7

1

6

2

1

17 (58.6)

NR

4

2

6

0

0

12 (41.4)

Azathioprine

8

R

1

–

0

–

–

1 (12.5)

NR

3

–

4

–

–

7 (87.5)

Mycophenolate Mofetil

3

R

1

–

0

–

–

1 (33.3)

NR

1

–

1

–

–

2 (66.6)

Infliximab

6

R

1

0

1

–

–

2 (33.3)

NR

1

1

1

–

–

3 (50)

Adalimumab

8

R

1

2

4

–

–

7 (87.5)

NR

0

0

1

–

–

1 (12.5)

Surgery: no. of children N (%)

2

1

9

0

0

12 (41.4)

No. of procedures

Cataract incl. Pars planar vitrectomy/ lensectomy

2

1

10

0

0

13

Corneal chelation

0

0

2

0

0

2

Evisceration

0

0

1

0

0

1

  1. Responders (R) had inactive disease on treatment. In non-responders (NR), treatment was escalated to one of the additional DMARDs then a TNFi or directly to a TNFi